BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23089566)

  • 1. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.
    Meyer SC; O'Meara A; Buser AS; Tichelli A; Passweg JR; Stern M
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):440-4. PubMed ID: 23089566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
    Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
    Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of iron parameters in patients undergoing allo-SCT.
    Bazuaye GN; Buser A; Gerull S; Tichelli A; Stern M
    Bone Marrow Transplant; 2012 Jan; 47(1):60-4. PubMed ID: 21399668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
    Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
    Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
    Kim YR; Kim JS; Cheong JW; Song JW; Min YH
    Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
    Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
    Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between thymic function and allogeneic hematopoietic stem cell transplantation outcome: results of a pediatric study.
    Saglio F; Cena S; Berger M; Quarello P; Boccasavia V; Ferrando F; Pittana L; Bruno B; Fagioli F
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1099-105. PubMed ID: 25708218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.
    Akı ŞZ; Suyanı E; Cengiz M; Özenirler S; Elbeğ Ş; Paşaoğlu H; Sucak GT
    Biol Blood Marrow Transplant; 2015 May; 21(5):948-53. PubMed ID: 25681034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
    Pullarkat V; Blanchard S; Tegtmeier B; Dagis A; Patane K; Ito J; Forman SJ
    Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital.
    Escobar K; Rojas P; Ernst D; Bertin P; Nervi B; Jara V; Garcia MJ; Ocqueteau M; Sarmiento M; Ramirez P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):176-9. PubMed ID: 25139214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
    Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
    Br J Haematol; 2009 Aug; 146(3):310-6. PubMed ID: 19508292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.
    Altès A; Remacha AF; Sureda A; Martino R; Briones J; Canals C; Brunet S; Sierra J; Gimferrer E
    Bone Marrow Transplant; 2002 Jun; 29(12):987-9. PubMed ID: 12098067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.
    Sivgin S; Baldane S; Kaynar L; Kurnaz F; Pala C; Ozturk A; Cetin M; Unal A; Eser B
    Neoplasma; 2012; 59(2):183-90. PubMed ID: 22248276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation.
    Pilon S; Jedrysiak D; Sheppard D; Bredeson CN; Tay J; Allan DS
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):364-70. PubMed ID: 25445635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
    Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.